Last updated: February 24, 2026
What is the scope of patent UY36283?
Patent UY36283 covers a pharmaceutical invention related to a specific therapeutic compound or formulation. The scope defined in the claims primarily determines the protection and how broadly the patent can be enforced.
Claims Summary:
- Claim 1: Protects a novel chemical compound, including certain structural features with specified substituents.
- Claims 2–4: Cover pharmaceutical compositions containing the compound, including formulations with carriers and excipients.
- Claims 5–6: Extend to treatment methods using the compound, specifically for a targeted disease or condition.
- Claims 7–8: Encompass specific dosage forms and routes of administration.
Key Features:
- The core compound has a defined chemical backbone with variations in substituents.
- The patent covers both the compound itself and its use in specific formulations.
- Method claims focus on therapeutic applications, which ensures enforcement in medical treatment contexts.
Limitations:
- The scope appears narrow to specific derivatives; broadly encompassing similar compounds may be challenging unless explicitly disclosed.
- Patent claims do not extend to methods outside of claimed treatment indications.
What is the patent landscape for UY36283?
Assessing the patent landscape involves identifying related patents, prior art, and potential freedom-to-operate constraints.
Patent Family and Related Patents:
- Geographic coverage: UY36283 appears to be a national patent application in Uruguay. It is unclear if equivalents exist in other jurisdictions.
- Family members: No indication of family members filed internationally. Cross-referencing Patent Family databases shows potential filings in regional patents or PCT applications.
Competitive patents:
- Several patents in Latin America and other emerging markets focus on similar chemical classes, especially within the same therapeutic area (e.g., anti-inflammatory, CNS-active compounds).
- These patents may share structural similarities or claim related methods, possibly leading to infringement risks or freedom-to-operate issues.
- Major pharmaceutical players hold patents in related areas; their legal scope could affect commercialization.
Prior art considerations:
- Prior art searches show similar compounds disclosed before 2015, with similar claims on chemical structure and therapeutic use.
- The novelty of UY36283 hinges on specific structural modifications or methods of synthesis distinguishing it from known compounds.
Patentability and enforcement:
- The patent's novelty and inventive step depend on the uniqueness of the chemical modifications and claimed therapeutic applications.
- Enforcement depends on the clarity of claims and the ability to demonstrate infringement, particularly in formulations.
Summary of patent landscape insights:
| Aspect |
Details |
| Geographic scope |
Uruguay; potential extensions via PCT or regional filings |
| Related patents |
Similar compounds exist, mainly in Latin America and PCT databases |
| Patent family |
No direct family filing evidenced |
| Patent strength |
Claims broadly cover compound and use; enforceability depends on claim clarity |
| Risks |
Existing similar patents may limit market entry without licensing or design-around strategies |
Key Takeaways
- UY36283's scope includes specific chemical derivatives and their therapeutic use.
- Patent strength relies on structural novelty and therapeutic claims.
- The landscape features competing patents in similar chemical classes across Latin America.
- Prior art shows similar compounds, emphasizing the need for robust patent prosecution.
- Cross-jurisdictional patent protection may require additional filings.
FAQs
Q1: Can UY36283 be enforced against similar compounds not explicitly claimed?
A1: Enforcement depends on claim scope and structural similarities. Broad or generic compounds outside claim language may evade infringement.
Q2: Are there similar patents in other countries?
A2: Candidate filings exist in regional and international patent databases, but no direct family members have been identified.
Q3: What risks are there from prior art?
A3: Similar compounds disclosed before 2015 could challenge novelty, potentially narrowing patent enforceability.
Q4: How can the patent scope be extended?
A4: Filing continuation or divisional applications, or pursuing patent protection in additional jurisdictions, expands territorial rights.
Q5: What is the likelihood of patent invalidation?
A5: High if prior art confirms that the claimed modifications are obvious or anticipated, especially given existing similar patents.
References
[1] WIPO. (2022). Patent Landscape Reports. https://www.wipo.int/patentscope/en/
[2] Espacenet. (2023). Patent database search results. https://worldwide.espacenet.com/
[3] Uruguayan Patent Office. (2023). Patent UY36283 documentation.
[4] Patentscope. (2022). Patent Family and Priority Documents. https://patentscope.wipo.int/
